维普中文期刊产品整合服务
43篇 您的检索式:作者名="Viaud S"
    题名 作者 年代 出处 被引量
1Macrophage activation switching: an asset for the resolution of inflammation 显示文摘Porcheray F Viaud S Rimaniol A C 2005Clin Exp Immunol2005,142,3:1
2Updated technology to produce highly immunogenie dendritic cell-derived exosomes of clinical grade : a critical role of interferon-y 显示文摘Viaud S Ploix S Lapierre V 2011J Immunother2011,34,1:1
3Dendritic cell-derived exosomes for cancer immunotherapy:what's next?显示文摘Viaud S Théry C Ploix S 2010Cancer Res2010,70,4:1
4Identification of neuronal substrates implicates Pak5 in synaptic vesicle trafficking 显示文摘Strochlic T I Concilio S Viaud J 2012Proc Natl Acad Sci USA2012,109,11:1
5Macrophage activation switching:an asset for the resolution of inflammation显示文摘Porcheray F Viaud S Rimaniol AC 2005Clin Exp Immunol2005,142,3:1
6Dendritic cell-derived exosomes for cancer immunotherapy: what's next? 显示文摘Viaud S Thrry C Ploix S 2010Cancer Res2010,70,4:1
7Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role forNKG2D ligandsand IL-15 Ralpha显示文摘Viaud S Terme M Flament C 2009PlosOne2009,4,3:1
8Dendritic cell-derived exo- somes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha 显示文摘Viaud S Terme M Flarnent C 2009PLoS One2009,4,:1
9Macrophage activation switching: an asset for the resolution of inflammation 显示文摘Porcheray F Viaud S Rimaniol A C 2005Clinical & Experimental Immunology2005,142,:1
10Dendritic cell-derived exosomes as immunotherapies in the fight against cancer 显示文摘Pitt JM Charrier M Viaud S 2014J Immunol2014,193,3:1
11Exosomes for the treatment of human maligancies 显示文摘Viaud S Ullrich E Zitvogel L 2008Horm Metab Res2008,40,2:1
12The Janus face of dendritic cells in cancer显示文摘Chaput N Conforti R Viaud S 2008Oncogene2008,27,45:1
13Genomic analysis of the necrotrophic fungal pathogens Sclerotinia sclerotiorum and Botrytis cinerea显示文摘Amselem J Cuomo C A van Kan J A Viaud M Benito E P Couloux A Coutinho P M de Vries R P Dyer PS Fillinger S Fournier E Gout L Hahn M Kohn L Lapalu N Plummer K M Pradier J M Quévillon E Sharon A Simon A ten Have A Tudzynski B Tudzynski P Wincker P Andrew M Anthouard V Beever R E Beffa R Benoit I Bouzid O Brault B Chen Z Choquer M Collémare J Cotton P Danchin E G Da Silva C Gautier A Giraud C Giraud T Gonzalez C Grossetete S Güldener U Henrissat B Howlett B J Kodira C Kretschmer M Lappartient A Leroch M Levis C Mauceli E Neuvéglise C Oeser B Pearson M Poulain J Poussereau N Quesneville H Rascle C Schumacher J Ségurens B Sexton A Silva E Sirven C Soanes D M Talbot N J Templeton M Yandava C Yarden O Zeng Q Rollins J A Lebrun M H Dickman M 2011PLoS Genetics2011,7,10:1
14A class Ⅲ histidine ki-nase acts as a novel virulence factor in Botrytis cinerea显示文摘Viaud M Fillinger S Liu W W 2006MPMI2006,19,:1
15Macro- phage activation switching: an asset for the resolution of inflammation 显示文摘Porcheray F Viaud S Rimaniol AC 2005Clin Exp Immunol2005,142,:1
16Why should we need the gut microbiota to respond to cancer therapies显示文摘Viaud S Daill~re R Yamazaki T 2014Oncoimmunology2014,3,27:1
17The intestinal microbiota mod ulates the anticancer immune effects of cyclophosphamide显示文摘Viaud S Saceheri F Mignot G 2013Sci ence2013,342,:1
18hnmunomodulatory effects of cyclophosphamide and implementations for vaccine design 显示文摘Sistigu A Viaud S Chaput N 2011Semin Immunopathol2011,33,4:1
19Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IE-15R alpha显示文摘Viaud S Terme M Flament C 2009PLoS ONE2009,4,3:1
20Immunomodulatory effects of cyclophosphamide and implementations for vaccine design 显示文摘Sistigu A Viaud S Chaput N 2011Semin Immunopathol2011,33,4:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费